Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specified

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

A quantitative immunoassay is a laboratory procedure designed to measure the concentration of a specific chemical substance, known as an analyte, in a biological sample. This type of testing is distinct in that it focuses on substances other than antibodies or antigens that the body produces in response to infectious agents. The term "immunoassay" refers to a variety of techniques that utilize the principles of immunology to detect and quantify substances. In this context, the analytes being measured can be associated with a wide range of non-infectious diseases and disorders, such as myasthenia gravis, pancreatic disease, and parathyroid disease, among others. Quantitative testing is crucial as it provides precise measurements of the levels of these substances, which can be critical for diagnosis, monitoring, and treatment decisions. The results of these tests can help healthcare providers understand the underlying conditions affecting a patient. For instance, specific substances that may be evaluated using this code include neuronal antibodies, cytokines, and vascular endothelial growth factor, which are important in various clinical scenarios. It is important to note that while this code encompasses a broad range of quantitative immunoassays, it specifically excludes tests that utilize the radioimmunoassay (RIA) method. RIA is a specialized technique that employs radioisotope-labeled antigens to detect minute quantities of substances, and it is reported under a different code (CPT® Code 83519). When using CPT® Code 83520, it is essential to report each analyte tested separately, as multiple tests for different substances will require multiple submissions of this code. This structured approach ensures accurate billing and documentation for the laboratory services provided.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The quantitative immunoassay represented by CPT® Code 83520 is indicated for the detection and measurement of various chemical substances (analytes) that are not related to infectious agents. The following conditions and diseases may warrant the use of this testing method:

  • Myasthenia Gravis - A chronic autoimmune neuromuscular disorder that leads to varying degrees of weakness of the skeletal muscles.
  • Pancreatic Disease - Conditions affecting the pancreas, which may include pancreatitis or pancreatic cancer, necessitating the measurement of specific pancreatic enzymes or markers.
  • Parathyroid Disease - Disorders related to the parathyroid glands, which regulate calcium levels in the blood, may require assessment of parathyroid hormone levels or related analytes.
  • Other Non-Infectious Diseases - A variety of other conditions may also be evaluated using this testing method, depending on the specific analytes being measured.

2. Procedure

The procedure for conducting a quantitative immunoassay using CPT® Code 83520 involves several key steps, which are outlined as follows:

  • Sample Collection - A biological sample, typically blood or serum, is collected from the patient. This sample serves as the basis for the immunoassay testing.
  • Preparation of Reagents - Specific reagents are prepared, which may include antibodies or other substances that will interact with the analyte of interest. These reagents are crucial for the binding process that allows for the detection of the analyte.
  • Incubation - The sample is mixed with the prepared reagents and incubated under controlled conditions. This step allows the analyte to bind to the antibodies or other substances, forming a complex that can be measured.
  • Measurement - After incubation, the bound complexes are measured using appropriate detection methods. This may involve fluorescence, colorimetric, or other techniques that quantify the amount of analyte present in the sample.
  • Data Analysis - The results are analyzed to determine the concentration of the analyte in the sample. This quantitative data is then reported to the healthcare provider for interpretation and further clinical decision-making.

3. Post-Procedure

Post-procedure care following a quantitative immunoassay using CPT® Code 83520 typically involves the interpretation of results by the healthcare provider. The provider will review the quantitative data obtained from the test to assess the patient's condition and determine any necessary follow-up actions. Depending on the results, further testing or treatment may be indicated. It is also essential for the laboratory to ensure proper documentation of the test results and any relevant clinical information to support ongoing patient care and compliance with billing requirements.

Short Descr IMMUNOASSAY QUANT NOS NONAB
Medium Descr IMMUNOASSAY ANALYTE QUANTITATIVE NOS
Long Descr Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; quantitative, not otherwise specified
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) Yes
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 9
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
GA Waiver of liability statement issued as required by payer policy, individual case
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
Q4 Service for ordering/referring physician qualifies as a service exemption
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
GZ Item or service expected to be denied as not reasonable and necessary
RT Right side (used to identify procedures performed on the right side of the body)
GW Service not related to the hospice patient's terminal condition
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
51 Multiple procedures: when multiple procedures, other than e/m services, physical medicine and rehabilitation services or provision of supplies (eg, vaccines), are performed at the same session by the same individual, the primary procedure or service may be reported as listed. the additional procedure(s) or service(s) may be identified by appending modifier 51 to the additional procedure or service code(s). note: this modifier should not be appended to designated "add-on" codes (see appendix d).
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
AY Item or service furnished to an esrd patient that is not for the treatment of esrd
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
GC This service has been performed in part by a resident under the direction of a teaching physician
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GX Notice of liability issued, voluntary under payer policy
LT Left side (used to identify procedures performed on the left side of the body)
PO Excepted service provided at an off-campus, outpatient, provider-based department of a hospital
Q3 Live kidney donor surgery and related services
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
QW Clia waived test
X5 Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
XP Separate practitioner, a service that is distinct because it was performed by a different practitioner
Date
Action
Notes
2024-01-01 Changed Guideline information changed.
2011-01-01 Changed Short description changed.
2010-01-01 Changed Code description changed.
1993-01-01 Added First appearance in code book in 1993.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"